Biotech / BioTech / Drugs / Healthcare / Drug / Boston / Boston blog main / Boston top stories / National blog main / National top stories / New York blog main / Alexandria Real Estate Equities / Amgen / Atomwise / Berg Pharma / big data / BostonVC / Celgene / Colin Hill / Cornell / Data Analytics / drug discovery / Fort Rock Capital / Gene Network Sciences / GHO Capital / GNS Healthcare / Healthtech / Heritage Provider Network / Horizon Blue Cross of NJ / Iya Khalil / licensing / Life Sciences / Machine Learning / Mitsui / Precision Medicine / Qrativ / REFS / Regence Blue Cross Blue Shield / Reverse Engineering & Forward Simulation / series c / Software / startups / Tech / VC / Zambon Pharma

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

Posted on: Aug 23, 2017   |   Posted by: Biotech Mag Top

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

The investment arm of biotech giant Amgen has led a new $6 million round of funding in GNS Healthcare, CEO Colin Hill tells Xconomy. Amgen Ventures' new investment is a part of...

Continue reading ...